The iQ Group Global has announced two recent promotions within their executive team – officially appointing Jimena Hurtado as General Manager of their Clinical Research Corporation (CRC) business and Lei Xu as Director of their Asia Pacific Business Unit.
Jimena has been promoted after a short period as Acting General Manager of CRC. She brings over 17 years’ experience in life sciences development, sales, and human resource management.
CEO of iQ Group Global Dr George Syrmalis said her appointment will create a strong force to lead and execute the strategy and ensure continuous growth of the business
“Her extensive knowledge of the industry combined with her passion and commitment for the CRC Brand has resulted in the execution of pioneering strategies that continue to grow business, develop its presence in the market, and differentiate it as a strategic medical affairs business partner to the pharmaceutical industry,” he said.
Jimena described her approach as, “strategic and methodical, ensuring the CRC team achieves their business goals as planned.”
Lei Xu initially joined iQ Group Global in 2014 as Head of APAC Investor Relations.
“Lei Xu uses solidarity and cross functionality to lead project, making her a key contributor to our company’s growth,” said Dr Syrmalis.
“We may be young but we are strongly positioned to challenge our competitors in the pharmaceutical industry supported by our bedrock values,” said Dr Syrmalis.
“Continued success will aid in bridging the gap between capital and science to create the medicines of the future.”